Utibron Neohaler

Active Ingredient(s): Indacaterol + Glycopyrrolate
FDA Approved: * October 29, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Lungs (Pulmonary)

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist[5] developed by Novartis. It needs to be taken only once a day,[6] unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. Medical uses A Cochrane review found benefit in lung functi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Utibron Neohaler Respiratory (Inhalation) Capsule
NDC: 0078-0664
Labeler:
Novartis Pharmaceuticals Corporation
Utibron Neohaler Respiratory (Inhalation) Capsule
NDC: 63402-681
Labeler:
Sunovion Pharmaceuticals Inc.